AMA seeks to expand telehealth, reform payment system and prior authorization

By

During his presidential address at the AMA House of Delegates meeting, Gerald E. Harmon, MD, outlined five actions that he said policymakers must take to better support physicians.These actions are part of the AMA’s Recovery Plan for Physicians, an “ambitious” but “doable” roadmap that will help physicians move forward after 2 years of sacrifices during…

Data suggests no increase in pediatric hepatitis, adenovirus above pre-pandemic levels

By

Data reported in Morbidity and Mortality Weekly Report did not demonstrate an increase in pediatric hepatitis or adenovirus types 40/41 above pre-COVID-19 pandemic baseline levels.“Following identification of pediatric hepatitis cases of unknown etiology in the United States and the United Kingdom, CDC issued a request in April 2022 for U.S. providers to report additional cases,”…

AMA: Climate change is a public health crisis

By

Climate change is a public health crisis threatening the well-being of all people, the AMA declared via a policy it adopted during the annual meeting of its House of Delegates.“The scientific evidence is clear: our patients are already facing adverse health effects associated with climate change, from heat-related injuries, vector-borne diseases and air pollution from…

AGA releases position statements to improve CRC screening, eliminate existing barriers

By

The AGA has released a series of evidence-based position statements that support a nationwide colorectal cancer screening approach and aim to eliminate current barriers in the screening process.“CRC screening saves lives, but only if people get screened,” David Lieberman, MD, AGAF, chair of the AGA executive committee on the screening continuum and professor of medicine…

VIDEO: Outgoing AGA president highlights race in medicine, AI as key topics from DDW 2022

By

In a Healio video exclusive, John Inadomi, MD, AGAF, chair of the department of medicine at the University of Utah and immediate past president of the AGA, shares key takeaways from Digestive Disease Week 2022.Among meeting highlights were the return of in-person sessions, the impact of artificial intelligence and machine learning on health care, and…

Symptom frequency, severity lower after third SARS-CoV-2 mRNA vaccine vs. second in IBD

By

SAN DIEGO — Patients with inflammatory bowel disease experienced reduced symptom frequency and severity after a third SARS-CoV-2 mRNA vaccine compared with after a second, according to data presented at Digestive Disease Week 2022.“Our group and others have shown that symptoms after SARS-CoV-2 vaccination in those that receive primary vaccination with two doses of an…